Three Senses, Three Interfaces: How Cochlear, Retinal and Somatosensory Implants Differ

Sensory neuroprosthetics all work from the same basic premise: when the natural pathway for a sense is damaged, an implanted device can deliver electrical stimulation to a downstream part of the nervous system and evoke a usable percept. But where each device plugs into that system — and what kind of sensation it produces — varies enormously. A cochlear implant reaches the auditory nerve, a retinal implant targets surviving cells inside the eye, and a somatosensory prosthetic stimulates the peripheral nervous system or the brain itself. Understanding those interface differences explains why the three technologies deliver such different results: speech understanding for cochlear recipients, deliberately limited visual percepts for retinal implant users, and paresthetic touch feedback for people with prosthetic limbs.

Introduction to Sensory Neuroprosthetics

The three device classes compared here occupy very different stages of maturity. Cochlear implantation is a well-established clinical treatment, supported by policy documents that describe consistent effectiveness in speech reception and sound localization. Retinal implants are a more experimental field, with device designs split between two competing anatomical placements. Somatosensory prosthetics are the newest of the three, emerging from research that has largely demonstrated feasibility rather than everyday clinical use.

What unites them is the strategy of substituting electrical stimulation for a lost biological transduction step. Each device chooses a different target along its sensory pathway, and that choice determines what the patient perceives. The closer the stimulation lands to the brain's own processing hierarchy, the more the resulting percept depends on higher-level neural interpretation — and the more the outcome varies from person to person. This article compares the three technologies on exactly those dimensions and keeps to the general principles described in the cited research rather than any specific commercial device.

Comparative Overview of Sensory Neuroprosthetics

The table below juxtaposes the three prosthetic types against consistent criteria — the sense targeted, the neural interface used, and the typical functional outcome — so the distinctions are visible at a glance. It clarifies why a cochlear implant yields speech understanding while a somatosensory implant yields tactile feedback rather than vision or hearing.

Sensory neuroprosthetics compared by target sense, neural interface and functional outcome
Prosthetic Type	Target Sense	Neural Interface Target	Typical Functional Outcome
Cochlear implant	Hearing, for severe-to-profound sensorineural hearing loss with limited or no benefit from conventional hearing aids	Direct stimulation of the auditory nerve, bypassing the poorly functioning cochlea	Consistent clinical effectiveness in speech reception, especially in noise, and in sound localization with bilateral implants; outcomes still vary among users
Retinal implant	Vision, for certain forms of blindness involving lost photoreceptor function	Subretinal devices interface with bipolar cells in place of photoreceptors; epiretinal devices stimulate ganglion cells, the retina's output stage	An approximation of vision built on stimulating surviving retinal circuitry; device quality depends on thin, biocompatible, stable placement between retinal layers
Somatosensory prosthetic	Touch, to provide sensory feedback that improves motor control of prosthetic limbs	Peripheral nerves or the central nervous system, including primary somatosensory cortex and the cervical spinal cord	Paresthetic sensations — often described as electrical buzzing — but almost never proprioceptive sensations

Read down the interface column and the pattern is clear: each device sits at a different depth in its sensory pathway, from a peripheral nerve to a brain region. Read across the rows and the outcomes differ just as sharply, from speech understanding to buzz-like touch. No column of the comparison implies one device is superior; they serve different senses and different patient populations.

Cochlear Implants: Restoring Hearing

The cochlear implant is the benchmark case for sensory restoration. According to a clinical policy document from Healthy Blue of Kansas, a cochlear implant "directly stimulates the auditory nerve, bypassing the physiologic transduction of sound into neural impulses by a poorly functioning cochlea." That single design decision — skipping the damaged inner ear entirely — is what makes the device work for people whose hearing loss stems from the cochlea itself rather than the nerve beyond it.

The same policy summary reports that studies in adults with severe-to-profound hearing loss who received limited or no benefit from conventional hearing aids show "consistent clinical effectiveness in speech reception (especially in noise) and in sound localization with bilateral cochlear implants." The evidence base is broad enough to cover older adults: a 2025 retrospective cohort study by Zhan followed 221 adults aged 80 and older — 171 aged 80 to 89 and 50 aged 90 or older — with bilateral severe-to-profound sensorineural hearing loss undergoing implantation at a tertiary academic center, and the policy notes that recent evidence confirms advanced age alone does not preclude meaningful benefit.

Candidacy is not automatic, though. The policy describes an extensive evaluation process: psychological testing to assess the individual's ability to accept a central nervous system implant and participate in rehabilitation, a full medical history and physical examination to rule out active infection or contraindications to anesthesia or surgery, and advanced imaging such as computed tomography or MRI to evaluate the inner ear anatomy.

Retinal Implants: Approximating Vision

Retinal implants face a more delicate engineering problem than cochlear devices, because the retina is not a simple relay — it performs the first stages of visual processing itself. A technical review published in Biomedical Engineering Letters by Byungwook Park, Woojae Butterworth, Nayeong Lee and Sohee Kim describes two main strategies for reaching the surviving cells. Subretinal devices sit between retinal layers and "aim to directly interface with bipolar cells in place of photoreceptors," meaning they tap into the retina's own intermediate processing. Epiretinal devices instead stimulate ganglion cells, which the authors describe as "the final output stage of the retina," where the signals "already reflect visual information after primary processing within the retina."

That placement choice matters for what the patient perceives. A subretinal device rides on top of the retina's remaining circuitry, so the brain receives partially processed visual information; an epiretinal device injects signals at the retina's output, downstream of that processing. The same review sets out the physical constraints that follow from subretinal placement: the implanted structure must be sufficiently thin to minimize physical damage to surrounding retinal cells, must ensure long-term biocompatibility, and must establish a stable interface through closer contact with bipolar cells.

What the restored experience is like is best understood as an approximation rather than restored natural vision. The devices rely on whatever visual interpretation the brain can construct from stimulation of surviving retinal cells — a fundamentally different proposition from the speech-reception outcomes cochlear recipients achieve. This article's evidence does not detail specific acuity or object-recognition figures from retinal implant trials, so no numbers are claimed here.

Somatosensory Prosthetics: Enabling Tactile Feedback

Somatosensory prosthetics serve a different purpose from the other two: rather than restoring a lost sense for its own value, they exist to close the feedback loop that makes a prosthetic limb controllable. A review of sensory restoration for improved motor control of prostheses describes two contrasting implementations. In one, a bi-directional brain-computer interface, electrodes implanted in primary motor cortex recorded neural signals to control a robotic arm while stimulation was delivered through electrodes in primary somatosensory cortex to provide sensory feedback from that limb. In the other, feedback was delivered by electrical stimulation of the cervical spinal cord, while the prosthetic hand was controlled by electromyographic signals from muscles in the residual forearm, and stimulation amplitude was modulated by pressure signals from the prosthetic fingers during an object discrimination task.

Here the interface target is the central nervous system itself — cortex or spinal cord — rather than a peripheral sense organ. The sensations produced are correspondingly unlike natural touch. The review reports that most research participants "report experiencing paresthetic sensations (i.e. electrical buzzing) but almost never report proprioceptive sensations," the sense of a limb's position in space. That gap matters: without proprioception, users know pressure events but not where their prosthetic joint is.

The clinical significance of this work is framed carefully by the review: the results "established the feasibility of using electrical stimulation to restore somatosensation after limb amputation and laid the foundation for developing clinical systems to improve the functionality of prostheses." Feasibility, not yet routine clinical restoration, is the honest status of the field.

Common Challenges in Sensory Restoration

Three shared limitations cut across all three device classes. The first is outcome variability. Even in the most mature field, cochlear implantation, results vary considerably among users; the clinical policy describes consistent effectiveness in speech reception across study populations, not uniform individual outcomes, and age is one variable that has now been specifically studied rather than assumed.

The second is the non-natural quality of the restored percept. Somatosensory users describe electrical buzzing; cochlear recipients gain speech reception through a pathway that bypasses the cochlea's own transduction; retinal implant vision is an approximation built from stimulated surviving cells. In every case the percept is the brain's interpretation of electrical input, not a faithful reproduction of the original sense.

The third is engineering: stable, biocompatible, long-term interfaces are unsolved problems in common. The retinal review's requirement that an implant be thin enough to avoid damaging surrounding cells while maintaining close, stable contact with bipolar cells is representative of the precision these devices demand. The somatosensory examples show how far interface targets have extended — from peripheral nerves into cortex and spinal cord — and each step deeper raises the stability and safety stakes. The article does not attempt to cover electrode-materials research in more depth, as the retrieved evidence does not support it.

Advancing Sensory Restoration: A Path Forward

For a reader choosing among these technologies — or a student mapping the field — the decision-relevant conclusion is that continued research and development are crucial for overcoming current limitations and achieving more natural and integrated sensory experiences with neuroprosthetics. None of the three classes restores its sense fully, and the comparison above shows the restoration quality is governed by which neural interface a device uses and how the brain interprets its output.

The measurable indicator to watch is progress in developing decoding-based stimulation technologies and improving long-term stability of neural interfaces. Concretely, that means studies reporting whether retinal implants can move beyond approximations toward sharper percepts, whether somatosensory systems can move beyond paresthetic buzzing toward more natural touch, and whether cochlear outcome variability can be better predicted — each a published, comparable result rather than a marketing claim. This article has compared general principles and research findings, not specific commercial products, and offers no medical advice or recommendation of one device over another.